bpc-157 injection infection case report BPC 157 in Australia: Benefits, side effects, risks and legality BPC 157 in Australia: Benefits,

The most common dose for treating deficiency is 1,000 mcg

Research has explored iontophoresis, microneedle delivery, and specialized cream formulations to improve transdermal delivery

For a desired 100 mg dose at 200 mg/mL, you divide 100 200 getting 0.5 mL

BPC-157s angiogenic response has been described as more potent and consistent than standard angiogenic growth factors in comparative studies, and critically it functions without requiring special delivery systems or carriers, a significant limitation of most conventional growth factors

Radenkovic D, Reason, Verdin E

It is also a marker that can be tracked over time to monitor response to treatment